Plasma tool for destroying cancer cells — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/03/140325094818.htm
source : http://www.sciencedaily.com/releases/2014/03/140325094818.htm
source : http://www.sciencedaily.com/releases/2014/03/140320100816.htm
source : http://www.sciencedaily.com/releases/2014/02/140226174437.htm
source : http://www.sciencedaily.com/releases/2014/02/140225143939.htm
source : http://www.sciencedaily.com/releases/2014/02/140219142602.htm
Dartmouth began to investigate a scientific phenomenon called the Cherenkov effect in 2011. Our scientists and engineers theorized that by using Cherenkov emissions the beam of radiation could be "visible" to the treatment team. The ability to capture a beam of radiation would show: • how the radiation signals travel through the body • the dose of radiation to the skin • any errors in dosage…
source : http://www.sciencedaily.com/releases/2014/01/140120085056.htm
Men who engage in higher levels of physical activity have been reported to have a lower risk of prostate cancer recurrence and mortality compared with men who participate in little or no physical activity. The biological mechanisms underlying this association are not known. "Prior research has shown that men with prostate tumors containing more regularly shaped blood vessels have a more favorable prognosis compared with men with prostate tumors containing mostly irregularly shaped blood vessels," said Erin Van Blarigan, Sc.D., assistant professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco. "In this study, we found that men who reported walking at a brisk pace had more regularly shaped blood vessels in their prostate tumors compared with men who reported walking at a less brisk pace…
Despite similar results on objective assessments, "It appears that there is a difference in the perception of cosmetic outcomes between Caucasian and African-American patients," according to the study led by ASPS Member Surgeon Dr. Robert D. …
Senior Research Fellow Dr Collin Sones and Professor Rob Eason are working with colleagues from Medicine and the Institute of Life Sciences — Dr Spiros Garbis, Professor Peter Smith and Professor Saul Faust — to develop laser-printed paper-based sensors that can be used to detect biomarkers in cancer patients and see how they are responding to their chemotherapy treatment. …